After completing this activity, participants will

Have a better understanding of:

• The importance of a multidisciplinary approach of localized and metastatic soft tissue sarcoma in a reference centre for the management of STST
• The rationale for the use of anti-PDGFRa antibodies in patients with advanced soft-tissue sarcoma not amenable to surgery

Have increased knowledge regarding:

• The current unmet needs in Soft Tissue Sarcoma
• Key patient selection criteria to optimise therapeutic risk-benefit of available treatment options

Have a greater competence in:

• Selecting treatments appropriate to patients’ needs and goals of therapy